Shan YF - Search Results

1

Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1.

Yan HX, Wang HY, Zhang R, Chen L, Li BA, Liu SQ, Cao HF, Qiu XH, Shan YF, Yan ZH, Wu HP, Tan YX, Wu MC. Yan HX, et al. Among authors: shan yf. Hepatology. 2004 Sep;40(3):618-28. doi: 10.1002/hep.20360. Hepatology. 2004. PMID: 15349900

2

SIRPalpha negatively regulates differentiation of PC12 cell.

Kang B, Liang Y, Shan Y, Guo M, Liu S, Fu X, Cao H, Wu M, Wang H. Kang B, et al. Brain Res Mol Brain Res. 2005 Aug 18;138(2):205-14. doi: 10.1016/j.molbrainres.2005.04.007. Brain Res Mol Brain Res. 2005. PMID: 15964662

3

The role of p28GANK in rat oval cells activation and proliferation.

Shan YF, Zhou WP, Fu XY, Yan HX, Yang W, Liu SQ, Cao HF, Kang B, Wu MC, Wang HY. Shan YF, et al. Liver Int. 2006 Mar;26(2):240-7. doi: 10.1111/j.1478-3231.2005.01203.x. Liver Int. 2006. PMID: 16448463

4

Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status.

Shan YF, Huang YL, Xie YK, Tan YH, Chen BC, Zhou MT, Shi HQ, Yu ZP, Song QT, Zhang QY. Shan YF, et al. Med Oncol. 2011 Dec;28(4):1012-6. doi: 10.1007/s12032-010-9600-6. Epub 2010 Jun 23. Med Oncol. 2011. PMID: 20571936

5

NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-NRF2 signaling.

Yang Y, Zheng J, Wang M, Zhang J, Tian T, Wang Z, Yuan S, Liu L, Zhu P, Gu F, Fu S, Shan Y, Pan Z, Zhou W. Yang Y, et al. Cancer Sci. 2021 Feb;112(2):641-654. doi: 10.1111/cas.14744. Epub 2020 Dec 13. Cancer Sci. 2021. Retraction in: Cancer Sci. 2023 Jul;114(7):3057. doi: 10.1111/cas.15809 PMID: 33222332 Free PMC article. Retracted.

6

Decreased expression of LKB1 correlates with poor prognosis in hepatocellular carcinoma patients undergoing hepatectomy.

Huang YH, Chen ZK, Huang KT, Li P, He B, Guo X, Zhong JQ, Zhang QY, Shi HQ, Song QT, Yu ZP, Shan YF. Huang YH, et al. Among authors: shan yf. Asian Pac J Cancer Prev. 2013;14(3):1985-8. doi: 10.7314/apjcp.2013.14.3.1985. Asian Pac J Cancer Prev. 2013. PMID: 23679304 Free article.

7

miR-499A>G rs3746444 and miR-146aG>C expression and hepatocellular carcinoma risk in the Chinese population.

Shan YF, Huang YH, Chen ZK, Huang KT, Zhou MT, Shi HQ, Song QT, Yu ZP, Deng AM, Zhang QY. Shan YF, et al. Genet Mol Res. 2013 Nov 7;12(4):5365-71. doi: 10.4238/2013.November.7.11. Genet Mol Res. 2013. PMID: 24301908 Free article.

8

Primary squamous cell carcinoma of the stomach: a case report and literature review.

Gao S, Chen D, Huang L, Dai R, Shan Y. Gao S, et al. Int J Clin Exp Pathol. 2015 Aug 1;8(8):9667-71. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26464735 Free PMC article. Review.

9

Genetically engineered recombinant adenovirus expressing interleukin‑2 for hepatocellular carcinoma therapy.

Sun Y, Wu H, Chen G, Huang X, Shan Y, Shi H, Zhang Q, Zheng Y. Sun Y, et al. Mol Med Rep. 2018 Jan;17(1):300-306. doi: 10.3892/mmr.2017.7922. Epub 2017 Oct 27. Mol Med Rep. 2018. PMID: 29115604

10

A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion.

Wang K, Xiang YJ, Yu HM, Cheng YQ, Qin YY, Wang WJ, Zhang XP, Zheng YT, Shan YF, Cong WM, Dong H, Lau WY, Cheng SQ. Wang K, et al. Among authors: shan yf. Eur J Surg Oncol. 2022 Jun;48(6):1348-1355. doi: 10.1016/j.ejso.2021.12.466. Epub 2021 Dec 29. Eur J Surg Oncol. 2022. PMID: 34996665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters